Real-time enrollment status for this major depressive disorder clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 2:57 PM UTC
| NCT Number | NCT07592689 |
| Recruiting Status | Recruiting |
| Condition | Major Depressive Disorder |
| Phase | PHASE3 |
| Target Enrollment | 165 participants |
| Active Locations | 30 sites in the US |
| Sponsor | Definium Therapeutics US, Inc. |
| Last Updated on CT.gov | October 5, 2026 (1 week ago) |
As of October 12, 2026: Clinical trial NCT07592689 is currently recruiting participants. This phase3 study for major depressive disorder is actively seeking new participants at 30 locations across the United States. The study is sponsored by Definium Therapeutics US, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07592689 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 30 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07592689 was last updated 1 week ago (October 5, 2026). HelloStudys verifies this status automatically.